Axonics, Inc. Stock
Stocks
AXNX
US05465P1012
Medical Equipment, Supplies & Distribution
| 18/11/24 | Boston Scientific Closes Acquisition of Axonics, Inc. | AQ |
| 16/11/24 | Boston Scientific Closes Acquisition of Axonics, Inc. | PR |
| 08/11/24 | Axonics : Reports Third Quarter 2024 Financial Results Form 8 K | PU |
| 08/11/24 | Axonics: Q3 Earnings Snapshot | AQ |
| 08/11/24 | Axonics Reports Third Quarter 2024 Financial Results | BU |
| 1 day | +0.75% |
| 3 years | 48.3 |  | 71.05 |
| 5 years | 38.41 | | 79.92 |
| 10 years | 11.95 | | 79.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 53 | 01/10/2013 | |
Kari Keese
DFI | Director of Finance/CFO | 41 | 02/10/2023 |
Rinda Sama
COO | Chief Operating Officer | 47 | 01/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert McNamara
BRD | Director/Board Member | 69 | 01/02/2018 |
Nancy Snyderman
BRD | Director/Board Member | 74 | 08/04/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/11/24 | Issuer sale | Executive/Senior Manager | 59,355 | 0.1161% | ||
| 15/11/24 | Issuer sale | Responsable ventes & marketing | 109,664 | 0.2145% | ||
| 15/11/24 | Issuer sale | Chief Technology Officer | 63,237 | 0.1237% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | -.--% | - | - | 3.63B | |
| +0.20% | +5.31% | -18.40% | +9.76% | 181B | |
| -0.73% | +7.09% | -1.08% | +30.33% | 116B | |
| +0.49% | +6.25% | -21.30% | +9.06% | 113B | |
| +3.83% | +5.50% | -50.59% | -5.64% | 79.83B | |
| -0.14% | +5.27% | +5.00% | +79.86% | 65.06B | |
| +0.12% | +1.44% | +13.70% | +74.75% | 54.35B | |
| -1.04% | +4.35% | +1.40% | -26.08% | 52.23B | |
| +2.41% | +8.18% | -11.81% | +31.75% | 44.15B | |
| -1.90% | +2.29% | +29.19% | +2.28% | 32.47B | |
| Average | +0.40% | +5.18% | -5.99% | +22.90% | 82.07B | |
| Weighted average by Cap. | +0.41% | +5.50% | -11.29% | +20.63% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
